In the wake of a big data breach and a sizable new round of layoffs, 23andMe's troubles have some people looking to delete ...
Amid its plummeting stock value, layoffs and cuts to its drug R&D program, the battered company is carrying on.
It was a simple process. You’d collect a saliva sample, ship it off, and within six weeks, you’d receive a complete ancestral ...
Johns Hopkins researchers have developed a powerful new AI tool called "Splam" that can identify where splicing occurs in ...
U.S. District Judge Edward Chen, of the Northern District of California, preliminary approved the 23andMe settlement, ...
No. 23andMe is considered a direct-to-consumer genetic testing company, and transactions with the company are considered ...
From an air fryer to a Wordle board game, these under-$30 Walmart picks are the ultimate crowd-pleasers. Black Friday may be ...
NEW YORK (AP) — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the struggling genetic testing company attempts to slash costs.
A federal judge granted early approval to a $30 million settlement to resolve claims 23andMe Inc. failed to protect the ...
Imagine unlocking the secrets within your DNA that hold the key to a healthier, more fulfilling life. While popular DNA tests ...
The restructuring arrives during a period of turmoil at 23andMe, which has recently included a high-profile data breach and several rounds of previous layoffs.
23andMe, the struggling ancestry tracing company, continues to spiral, raising questions about its business prospects and what could happen to its sensitive customer genetic testing data.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback